Skip to content
Open access

Demographic time bomb in COPD (1990–2050)

Aug 2026 · Medicine · Vol 105, pp. e50162 · 0 citations · 48 references
Medicine

TL;DR

This study provides the first comprehensive analysis of COPD epidemiology from 1990 to 2021 using Global Burden of Disease 2021 data, integrating multimodel projections to 2050 and risk factor attribution across SDI quintiles.

Abstract

Chronic obstructive pulmonary disease (COPD) is a leading global cause of morbidity and mortality, characterized by irreversible airflow limitation and progressive symptoms. Despite declining age-standardized rates (ASRs), absolute burdens are rising due to population aging and growth, particularly in low- and middle-Sociodemographic Index (SDI) regions. This study provides the first comprehensive analysis of COPD epidemiology from 1990 to 2021 using Global Burden of Disease 2021 data, integrating multimodel projections to 2050 and risk factor attribution across SDI quintiles. The study extracted COPD incidence, prevalence, mortality, and disability-adjusted life years (DALYs) from the Global Burden of Disease 2021 study (204 countries, 1990–2021). Trends were analyzed via Joinpoint regression, average annual percentage change, age-period-cohort models, and decomposition analysis (population growth/aging/epidemiological shifts). Risk factor burdens (smoking, ambient PM2.5, and household air pollution) were quantified using population attributable fractions. Bayesian age-period-cohort models projected the age-standardized incidence rate, age-standardized mortality rate, and age-standardized DALY rate to 2050. Globally, the age-standardized incidence rate, age-standardized mortality rate, and DALY rate declined (average annual percentage change: −0.05%, −1.49%, and −1.48%, respectively), while absolute cases, deaths, and DALYs increased (213.4 million cases and 1.69 million deaths in 2021). Low-/middle-SDI regions exhibited 2- to 3-fold higher ASRs than high-SDI areas. An inverted V-shaped relationship emerged between SDI and COPD burden, peaking at an SDI of 0.4 to 0.6. Smoking (38%–55% of DALYs), ambient PM2.5 (15%–25%), and household air pollution (0%–55%) dominated risk factors, with marked SDI-based heterogeneity. Projections indicate stable/declining ASRs globally to 2050, but rising absolute burdens in low-SDI nations. COPD remains a critical public health challenge, with shifting burdens from mortality to high prevalence. Targeted interventions in low-SDI regions – clean energy adoption, community spirometry screening, and culturally tailored tobacco control – are imperative to meet the United Nations 2030 noncommunicable disease mortality targets.

Read PDF

Similar papers

Open access Sep 2026

Global, regional, and 204 countries burden of disease attributed to secondhand smoke-related COPD, 1990–2021: A secondary data analysis of the Global Burden of Disease Study 2021

INTRODUCTION Chronic obstructive pulmonary disease (COPD) imposes a significant economic burden on global public health systems. This secondary data analysis aims to estimate the disease burden of COPD attributable to secondhand smoke exposure from 1990 to 2021. METHODS Data on mortality, age-standardized mortality rat...

Qian-Shuo Huang, Le-Wen Fu, Sajid Ali et al. · 0 citations
Open access Sep 2026

Tobacco-driven digestive disease burden: A China–US comparative analysis, 1990–2035

Introduction Smoking is a well-established risk factor for digestive diseases, yet direct comparisons of smoking-attributable digestive disease burden between nations with divergent tobacco control trajectories remain scarce. This study compared temporal trends, driving factors, and future projections of this burden in...

Zhuo-Fu Cheng, Xue Luo, Da Yan et al. · 0 citations
Open access Oct 2026

Trends in mortality involving chronic obstructive pulmonary disease and obesity in the United States, 1999–2023

Chronic obstructive pulmonary disease (COPD) and obesity are major US public health conditions that frequently coexist. Despite adverse respiratory and cardiometabolic effects of obesity, an apparent “obesity paradox,” whereby obesity has been associated with lower mortality in some patients with COPD, has been describ...

AM Khan, Syed Azfar Hussain, Z. Ahmad et al. · 0 citations
Open access Aug 2026

Smoking-attributable burden of musculoskeletal disorders, 1990–2021, with exploratory projections to 2050: A secondary dataset analysis of the Global Burden of Disease Study 2021

The persistence of absolute burden despite declining ASDR may warrant greater consideration in future tobacco-related burden assessments and rehabilitation planning, while causal and policy interpretations warrant cautious interpretation as this is an ecological modelling study.

Z. Fu, Yunhui Zhang, Zhaojun Chen · 0 citations
Open access Sep 2026

The shifting burden of tracheal, bronchus and lung cancer in ageing Asia: structural drivers and projections to 2050

Abstract Background Tracheal, bronchus, and lung (TBL) cancer remains a major cause of cancer morbidity and mortality. We quantified historical trends, structural drivers, inequality, and future burden of TBL cancer among Asian adults aged ≥60 years. Methods Using Global Burden of Disease 2023 data, we assessed inciden...

Lei Zhu, Lin-Ping Fan, Jiang-Na Wen et al. · 0 citations
Open access Aug 2026

Chronic Respiratory Diseases in the 2023‐Defined WHO Western Pacific Region: Burden and Trends From GBD 2023

The burden increased sharply with age, remained higher in males, and was dominated by chronic obstructive pulmonary disease, accounting for 75.3% of DALYs, whereas six‐country comparisons showed marked regional heterogeneity.

Zhang Yue, Yi-Cheng Fu, Wen-Hui Zuo et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.